Myocardial infarction · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) showed no clear difference in myocardial infarction compared with warfarin; GRADE not reported.
1 finding from 1 review
Minor bleeding · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) showed no clear difference in minor bleeding compared with warfarin (low certainty).
1 finding from 1 review
Gastrointestinal bleeding · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) showed no clear difference in gastrointestinal bleeding compared with warfarin (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) probably leads to lower intracranial haemorrhage compared with warfarin (moderate certainty).
1 finding from 1 review
All‐cause mortality · atrial fibrillation patients with CKD
Direct oral anticoagulants (DOAC) showed no clear difference in all‐cause mortality compared with warfarin (moderate certainty).
1 finding from 1 review
Total VTE · people requiring prevention of venous thromboembolism
1 finding from 1 review
Symptomatic VTE · people requiring prevention of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · people requiring prevention of venous thromboembolism
1 finding from 1 review
Proximal DVT · people requiring prevention of venous thromboembolism
1 finding from 1 review
Total PE · people requiring prevention of venous thromboembolism
1 finding from 1 review
Major bleeding · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes major bleeding compared with variable dose warfarin (very low certainty).
1 finding from 1 review
All causes of death · people requiring prevention of venous thromboembolism
1 finding from 1 review
Total VTE · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes total VTE compared with 1 mg warfarin (very low certainty).
1 finding from 1 review
Symptomatic VTE · people requiring prevention of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes total DVT compared with 1 mg warfarin (very low certainty).
1 finding from 1 review
Proximal DVT · people requiring prevention of venous thromboembolism
1 finding from 1 review
Total PE · people requiring prevention of venous thromboembolism
1 finding from 1 review
Major bleeding · people requiring prevention of venous thromboembolism
It is very uncertain whether fondaparinux changes major bleeding compared with 1 mg warfarin (very low certainty).
1 finding from 1 review
All causes of death · people requiring prevention of venous thromboembolism
1 finding from 1 review
All studies · patients with the initiation of oral anticoagulation
It is very uncertain whether 5 mg changes all studies compared with 10 mg (very low certainty).
1 finding from 1 review